Provided herein are compounds that inhibit or partially inhibit the activity of leucine rich repeat kinases. Also provided herein are methods of treatment of CNS disorders comprising administration of inhibitors of leucine rich repeat kinases.
[EN] LRRK2 INHIBITORS<br/>[FR] INHIBITEURS DE LRRK2
申请人:ZENOBIA THERAPEUTICS INC
公开号:WO2012178015A3
公开(公告)日:2013-05-10
A General Oxindole Synthesis
作者:George J. Quallich、P. M. Morrissey
DOI:10.1055/s-1993-25790
日期:——
A general synthesis of indol-2(3H)-ones (oxindoles), was developed based on the addition of dimethyl malonate to commercially available halonitrobenzenes. The advantage of this route over many other oxindole syntheses was the regiochemical control of the substitution pattern on the aromatic ring.